FDA to focus on data in new ‘top strategic priority’

07-12-2018

FDA to focus on data in new ‘top strategic priority’

carmendorin / iStockphoto.com

The US Food and Drug Administration (FDA) has announced a new strategy for the use of “real-world evidence” (RWE) and “real-world data” (RWD) to improve its regulation of new drugs.


FDA, real-world evidence, real-world data, Scott Gottlieb, 21st Century Cures Act, Framework for the FDA’s Real-World Evidence Program

LSIPR